The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price purchase order to Seqirus USA Inc. for the storage and rotation of influenza vaccine stockpiles. This procurement aims to ensure the availability of pediatric vaccines manufactured by Seqirus USA Inc. in the national stockpile, which is critical for responding to potential disease outbreaks or vaccine shortages. Interested parties may express their interest and capability to fulfill this requirement, with all responses considered by the government within fifteen days of the notice's issuance. Quotations should be submitted via email to the contract specialist at uuu0@cdc.gov by close of business on October 22, 2024.